Explore the potential of Intra-National Education in India, bridging gaps between regions and enhancing student mobility for ...

Dr. Marty Makary, the FDA’s commissioner, said the program targets “dead time,” or about half the time between the launch of ...

Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own ...

Avalyn Pharma Inc. (Nasdaq: AVLN) ('Avalyn”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to ...

Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran ...

Clinuvel Pharmaceuticals (ASX:CUV) is conducting a Phase III trial to expand the indications for Scenesse (afamelanotide), ...

EXCLUSIVE: Open Roads: New Italian Cinema, the Italian cinema showcase hosted by Film at Lincoln Center and Cinecittà in New ...

Arkansas House passes funding for University of Arkansas in final days of fiscal session ...

Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing multiple cancer types Vienna, Austria, April 28, 2026 – Proxygen, a biotechnology company pioneering ...

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical ...

Avalyn Pharma Inc. (Nasdaq: AVLN) ("Avalyn"), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of ...